Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to new research. Photo by Adobe Stock/HealthDay News A person ...
Women with multiple sclerosis (MS) are significantly less likely than men to be treated with disease-modifying therapies (DMTs) and highly effective DMTs (HE-DMTs), a new study showed. At comparable ...
Share on Pinterest Certain diabetes medications may affect one’s risk of developing multiple sclerosis. Christina House/Los Angeles Times via Getty Images Multiple Sclerosis (MS) is a potentially ...
Researchers may have hit "gold" when it comes to the treatment of multiple sclerosis. An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising ...
Drugs currently used to treat Type 2 diabetes may also prove useful for treatment of multiple sclerosis, according to studies at the University of Illinois at Chicago and the West Side Veterans ...
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study examined the ...
As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...
Initially, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have subsequently been marketed and widely used for weight loss. Now these medications are showing promise as a ...
Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback